Press Releases June 2, 2026 08:00 AM

electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub

electroCore to present at Planet MicroCap Las Vegas 2026 conference highlighting growth prospects and strategy

By Nina Shah ECOR

electroCore, Inc., a bioelectronic medicine company, announced it will present at the Planet MicroCap Las Vegas 2026 conference, with Interim President and CFO Joshua Lev delivering a presentation and meeting investors. The company focuses on non-invasive bioelectronic therapies for chronic pain and wellness, promoting its prescription and consumer wellness products.

electroCore to Present at the Planet MicroCap Las Vegas 2026 Powered by MicroCapClub
ECOR

Key Points

  • electroCore is presenting at a prominent microcap investor conference to enhance visibility and engagement with investors.
  • The company offers non-invasive bioelectronic products targeting chronic pain and general wellness, indicating growth potential in bioelectronics and healthcare technology sectors.
  • Management is actively sharing company strategy and growth opportunities, signaling transparency and investor outreach efforts.

ROCKAWAY, N.J., June 02, 2026 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that it will be presenting at Planet MicroCap Las Vegas 2026 Powered by MicroCapClub being held at the Bellagio Resort & Casino in Las Vegas, NV. Joshua Lev, Interim President and CFO, will deliver a presentation and host one-on-one investor meetings throughout the conference.

Planet MicroCap Las Vegas 2026 Powered by MicroCapClub Details:

Dates: June 17 - 18, 2026
Company Presentation: Wednesday, June 17 at 10:30 am PT
Location: Bellagio Resort & Casino, Las Vegas, NV Webcast: https://event.summitcast.com/view/bpjo3VVjZ25pp6SXpUua92/4CSAXUYpH7cP7oqVpDE3sB

Investors may also access a recent video interview featuring Joshua Lev with Robert Kraft discussing the Company’s strategy and growth opportunities here:
https://www.youtube.com/watch?v=TtuSgTQ2gWE

If you would like to book one-on-one investor meetings with electroCore and attend Planet MicroCap Las Vegas 2026, please register at https://planetmicrocapshowcase.com/.

About electroCore, Inc.

electroCore, Inc. is a bioelectronic technology company whose mission is to improve health and quality of life through innovative non-invasive bioelectronic technologies. The Company’s two leading prescription products, gammaCore® non-invasive vagus nerve stimulation (nVNS) and Quell® neurostimulator, treat chronic pain syndromes through non-invasive neuromodulation technology. Additionally, the company commercializes its handheld, and personal use Truvaga™ and TAC-STIM™ nVNS products utilizing bioelectronic technologies to promote general wellness and human performance.

For more information, visit www.electrocore.com.

About Planet MicroCap

Planet MicroCap hosts high-quality microcap investor conferences and events focused on connecting public companies, investors, and industry professionals. For more information about Planet MicroCap, please visit: https://planetmicrocap.com/

About MicroCapClub

MicroCapClub is an exclusive forum for experienced microcap investors to share and discuss microcap companies trading on global markets. Since 2011, members have profiled more than 1,500 microcap companies, with more than 300 becoming multi-baggers. For more information, visit https://microcapclub.com/

Contact:
ECOR Investor Relations
(973) 302-9253
[email protected]


Risks

  • Market adoption risk of bioelectronic medicine products impacting revenue growth in healthcare technology.
  • Dependence on successful communication of strategy and execution to microcap investors for capital and support, relevant to financial and investment sectors.
  • Potential competition and regulatory challenges in the medical device and wellness products sector may affect business expansion.

More from Press Releases

Eledon Announces Presentation of Updated Data from Investigator-Initiated Islet Transplant Trial of Tegoprubart in Patients with Type 1 Diabetes at American Diabetes Association (ADA) 2026 Scientific Sessions Jun 4, 2026 Xos Makes Its GFX Debut with Electric Vehicles, Powertrain Technology, and Mobile Charging for Public Fleets Jun 4, 2026 Satellogic to Participate in June Investor Conferences Jun 4, 2026 BIO GREEN MED SOLUTION, INC. ANNOUNCES BUSINESS COMBINATION AGREEMENT TO ACQUIRE FUTURE NRG SDN. BHD. Jun 4, 2026 SI-BONE To Present at Truist Securities 2026 MedTech Conference on June 16, 2026 Jun 4, 2026